Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,412,887
+$3,864,496 QoQ
Shares Held
264,468
+24.7% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#266
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $371,290,075 across 10 Drug Manufacturers - General names. GILD ranks #6 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,318 | $108,330,127 | |
| 2 | JNJ |
Johnson & Johnson
|
265,811 | $67,508,019 | |
| 3 | ABBV |
AbbVie Inc.
|
206,756 | $52,028,079 | |
| 4 | AMGN |
Amgen Inc
|
109,431 | $39,627,153 | |
| 5 | MRK |
Merck & Co., Inc.
|
273,534 | $35,149,119 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
264,468 | $33,412,887 | |
| 7 | PFE |
Pfizer Inc
|
635,140 | $15,294,171 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
228,360 | $13,158,103 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,412,887 | 264,468 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $29,548,391 | 212,014 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,760,213 | 283,202 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $34,952,568 | 314,888 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $36,365,360 | 328,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $36,842,376 | 328,803 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $39,300,941 | 425,473 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $39,452,756 | 470,572 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $40,905,076 | 596,197 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $30,741,413 | 419,678 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $30,390,739 | 375,148 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $26,867,638 | 358,522 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $24,466,488 | 317,458 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $21,947,473 | 264,523 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $21,543,799 | 250,947 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $17,017,926 | 275,862 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,583,341 | 203,581 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,374,237 | 241,787 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $12,654,616 | 174,282 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,966,198 | 142,680 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $8,311,402 | 120,700 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $8,740,173 | 135,234 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $5,945,258 | 102,047 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $6,274,767 | 99,300 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,223,753 | 80,891 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $4,362,021 | 58,347 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||